Dual isotope simultaneous imaging to evaluate the effects of intracoronary bone marrow-derived mesenchymal stem cells on perfusion and metabolism in canines with acute myocardial infarction

Biomedical Reports

Volumn 3, Issue 4, 2015, Pages 447-452

  Hao, Linjun ^a   Hao, Jin ^b   Fang, Wei ^c   Han, Chunlei ^d   Zhang, Kaixiu ^a   Wang, Xuemei ^a  

^a The Affiliated Hospital of Inner Mongolia Medical University   (China)

^b INNER MONGOLIA MEDICAL UNIVERSITY   (China)

^c FUWAI HOSPITAL   (China)

^d TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Acute myocardial infarction; Metabolism; Perfusion; Stem cell

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA ACTININ; ASPARTATE AMINOTRANSFERASE; AZACITIDINE; BROXURIDINE; CREATINE KINASE; CREATINE KINASE ISOENZYME; FLUORODEOXYGLUCOSE F 18; MYOSIN HEAVY CHAIN; TECHNETIUM 99M; TROPONIN T;

ACUTE HEART INFARCTION; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW DERIVED MESENCHYMAL STEM CELL; CONTROLLED STUDY; DOG; ELECTROCARDIOGRAPHY; FEMALE; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE CELL; HEART PERFUSION; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; INTRACORONARY DRUG ADMINISTRATION; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; METABOLISM; MICROFILAMENT; NONHUMAN; PROTEIN EXPRESSION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

CANIS FAMILIARIS;

EID: 84997256958     PISSN: 20499434     EISSN: 20499442     Source Type: Journal    
DOI: 10.3892/br.2015.474     Document Type: Article

References (19)

1. Keeley EC and Hillis LD: Primary PCI for myocardial infarction with ST-segment elevation. N Engl J Med 356: 47-54, 2007.
2. Martin-Rendon E, Brunskill SJ, Hyde CJ, Stanworth SJ, Mathur A and Watt SM: Autologous bone marrow stem cells to treat acute myocardial infarction: A systematic review. Eur Heart J 29: 1807-1818, 2008.
3. Penn MS (ed): Stem Cells and Myocardial Regeneration. 1st Edition. Humana Press, Totowa, p277, 2007.
4. Silva GV, Litovsky S, Assad JA, Sousa AL, Martin BJ, Vela D, Coulter SC, Lin J, Ober J, Vaughn WK, et al: Mesenchymal stem cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a canine chronic ischemia model. Circulation 111: 150-156, 2005.
5. Rodrigo SF, van Ramshorst J, Hoogslag GE, Boden H, Velders MA, Cannegieter SC, Roelofs H, Al Younis I, Dibbets-Schneider P, Fibbe WE, et al: Intramyocardial injection of autologous bone marrow-derived ex vivo expanded mesenchymal stem cells in acute myocardial infarction patients is feasible and safe up to 5 years of follow-up. J Cardiovasc Transl Res 6: 816-825, 2013.
6. Fukuda K and Fujita J: Mesenchymal, but not hematopoietic, stem cells can be mobilized and differentiate into cardiomyocytes after myocardial infarction in mice. Kidney Int 68: 1940-1943, 2005.
7. 18F-FDG in the assessment of myocardial perfusion and metabolism in patients with recent AMI and intracoronary stem cell injection. J Nucl Med 51: 1908-1916, 2010.
8. Saraste A, Kajander S, Han C, Nesterov SV and Knuuti J: PET: Is myocardial flow quantification a clinical reality? J Nucl Cardiol 19: 1044-1059, 2012.
9. Rahmim A and Zaidi H: PET versus SPECT: Strengths, limitations and challenges. Nucl Med Commun 29: 193-207, 2008.
10. Slart RH, Bax JJ, van Veldhuisen DJ, van der Wall EE, Dierckx RA and Jager PL: Imaging techniques in nuclear cardiology for the assessment of myocardial viability. Int J Cardiovasc Imaging 22: 63-80, 2006.
11. 18F-FDG PET. Eur J Nucl Med Mol Imaging 33: 716-723, 2006.
12. 99mTc-sestamibi single photon emission computed tomography for the assessment of myocardial viability. Nucl Med Commun 24: 251-257, 2003.
13. Hutton BF: The origins of SPECT and SPECT/CT. Eur J Nucl Med Mol Imaging 41 (Suppl 1): S3-S16, 2014.
14. Psaltis PJ, Zannettino AC, Worthley SG and Gronthos S: Concise review: Mesenchymal stromal cells: Potential for cardiovascular repair. Stem Cells 26: 2201-2210, 2008.
15. Pittenger MF and Martin BJ: Mesenchymal stem cells and their potential as cardiac therapeutics. Circ Res 95: 9-20, 2004.
16. Robey TE, Saiget MK, Reinecke H and Murry CE: Systems approaches to preventing transplanted cell death in cardiac repair. J Mol Cell Cardiol 45: 567-581, 2008.
17. Song L, Yang YJ, Dong QT, Qian HY, Gao RL, Qiao SB, Shen R, He ZX, Lu MJ, Zhao SH, et al: Atorvastatin enhance efficacy of mesenchymal stem cells treatment for swine myocardial infarction via activation of nitric oxide synthase. PLoS One 8: e65702, 2013.
18. Yang YJ, Qian HY, Huang J, Li JJ, Gao RL, Dou KF, Yang GS, Willerson JT and Geng YJ: Combined therapy with simvastatin and bone marrow-derived mesenchymal stem cells increases benefits in infarcted swine hearts. Arterioscler Thromb Vasc Biol 29: 2076-2082, 2009.
19. Soboleva EL, Gabbasov ZA, Agapov AA, Akchurin RS, Saburova OS, Romanov YA and Smirnov VN: Circulating bone marrow stem/progenitor cells in vascular atherogenesis and in the noninvasive diagnosis of coronary stenosis. Exp Clin Cardiol 10: 184-188, 2005.